International Patent: COMBINATIONS OF AN IAP INHIBITOR, A TYROSINE KINASE INHIBITOR AND AN ACTIVATOR OF THE TNF A INDUCED CELL DEATH PATHWAY AND THEIR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES OR DISORDERS SUCH AS CANCER OR PULMONARY DISEASES

GENEVA, Oct. 9 -- UNIVERSITY OF HOUSTON SYSTEM filed a patent application (US2025/023468) for “COMBINATIONS OF AN IAP INHIBITOR, A TYROSINE KINASE INHIBITOR AND AN ACTIVATOR OF THE TNF A INDUCED CELL DEATH PATHWAY AND THEIR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES OR DISORDERS SUCH AS CANCER OR PULMONARY DISEASES”. With publication no. WO/2025/217052, here are the other details related to the patent application:

Kind: Corrected version of pamphlet [A9]

IPC: A61K 31/132

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....